(2) Among patients with advanced ESCC not selected based on PD-L1 expression, the combination of toripalimab with chemotherapy (toripa-chemo) and sintilimab with chemotherapy (sint-chemo) emerged as the most efficacious in terms of OS. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.